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Endothelin is a potent vasoconstrictor peptide which has recently been localized in 
the gastrointestinal tract. We have investigated the transmembrane signaling 
properties of endothelin in isolated smooth muscle ceils of the rabbit rectosigmoid. 
Endothelin induced a dose dependent contraction of smooth muscle cells in a range of 
10 -1° to 10-6M. In normal buffer, contraction peaked at 30 see and was sustained for 
up to 8 rain. Incubation in 0Ca/2mM EGTA abolished the sustained contraction 
induced by endothelin, but had no effect on the initial transient contraction. 
Preincubation of saponin treated cells with G protein antlsera had no effect on control 
cell length. Preincubation of saponin treated isolated smooth muscle ceils with 
specific G protein antisera (rabbit antisera) for Goct or Gs for 60 minutes did not 
inhibit contraction induced by endothelin. Preincubation with an antiserum to Gi3ct 
inhibited the initial transient contraction induced by endothelin and preincubation with 
an antiserum to Gil_2Ct inhibited the sustained phase of the endothelin induced 
contraction. Our data indicate that: 1) Endothelin induces a direct sustained 
contraction of smooth cells from the rectosigmoid; 2) The transmembrane signalling 
of endothelin is through two specific GTP binding components that are Gict, one for 
the initial transient contraction, and the other for the sustained phase of the 
contraction. 
Endothelins are a newly described peptide family consisting of three peptides 
(ET-1,ET-2,ET-3) which are the most potent vasoconstrictive peptides known (1, 2, 3). The 
vasoconstrictive effects of ET-1 are long-lasting, so that a single small injection into the circulation 
of a rat increases the blood pressure for an hour or more. 
Two distinct receptors for endothelin have been described. Those receptors probably serve 
different functions. Each of the receptors belongs to the family of rhodopsin like receptors, with 
seven transmembrane domains, and each receptor is coupled to a G protein. One shows high 
specificity for ET-1 and the messenger RNA is widely distributed in the central nervous system, 
the heart and the lungs (ETA) (4). The other (5) is a non-selective receptor (ETB) but equally 
accepts all three endothelins, as well as sarafotoxins, and is coupled through a G protein to 
phospholipase C, leading to transient increases in intracellular free Ca ++. The messenger RNA for 
that receptor is not found in vascular smooth muscle. The discovery of three isopeptides of the 
endothelin family (7), ET-1, ET-2,ET-3, each possessing a diverse set of pharmacological activities 
of different potencies, suggests the existence of several different endothelin receptor subtypes 
(6, 7, 8, 9, 10). Endothelins may elicit biological responses by various signal transduction 
mechanisms, including the G protein - coupled activation of phospholipase C and the activation of 
voltage-dependent Ca++ channels (11, 12, 13). Thus, different subtypes of the endothelin receptor 
may use different signal-transduction mechanisms. 
Endothelin has also been shown to be present in the rat gastrointestinal tract (14) and high 
endothelin binding sites are shown to be present in muscle layer of the rat ileum, and shown to 
cause contraction of gastrointestinal smooth muscle (14). Endothelin like immunoreactivity was also 
localized to nerve bundles throughout the human colon and abundant 125I-ET-1 binding sites were 
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neural regulation of the colon (15). We have investigated the presence of endothelin receptors on 
isolated smooth muscle cells of the rabbit rectosigmoid and have investigated their transmembrane 
signaling properties. Our data indicate that endothelin induces a direct sustained contraction of 
smooth muscle cells from the rabbit rectosigmoid similar to the contraction induced by exogenous 
protein kinase C. The early transient peak is independent of extracellular calcium, while the 
sustained phase of the contraction is totally dependent on calcium from extracellular sources. The 
transmembrane signalling of endothelin for each phase of contraction is through a specific but 
different GTP binding component that is Gia. 
ExDerimental m'ocedures 
Isolation of Rabbit Rectosigmoid: The sphincteric region was identified as previously described 
(16). After anesthesia, the pelvic bone is exposed and opened and a 5 cm segment containing the 
terminal portion of the colon and rectum, including the anal sphincter, is measured and dissected 
free. The segment is opened with a midline incision along its anterior aspect, quickly rinsed, and 
pinned on a wax block at its in vivo length. The tissue is kept immersed in oxygenated Kreb's 
solution on ice. The junction of the rectal mucosa with the skin lining the outer portion of the canal 
is marked by sutures running through the whole thickness of the tissue; the external anal sphincter 
and the mucosa are removed by sharp dissection under a microscope, with care being taken not to 
disturb the sutures. Removal of the mucosa exposes the circular muscle layer; the circular fiber 
bundles are clearly visible. The internal anal sphincter, consisting of the distal most 3 mm of the 
circular muscle layer, ending at the junction of skin and mucosa, is discarded and a 5 cm aurad is 
removed and cells were isolated from this portion. 
Dispersion of Smooth Muscle Cells: The cells are isolated as previously described (17). Tissue 
from the circular layer was incubated for two successive 60-min periods at 31°C in 15 ml of Krebs- 
bicarbonate or HEPES buffer containing 0.1% collagenase (150 U/mg, Worthington CLS Type II, 
Freehold, NJ, USA) and 0.01% soybean trypsin inhibitor. At the end of the second enzymatic 
incubation period, the medium is filtered out through 500-1xm Nitex. The partly digested tissue left 
on the filter is washed four times with 50 ml of collagenase-free buffer solution. The tissue is then 
transferred into 15 ml of fresh buffer solution and incubated for 30 min to allow the cells to disperse 
spontaneously. Only the ceils that dissociate spontaneously in enzyme-free solution are used for 
functional studies. Ceils are counted in a hemocytometer and diluted as needed. Each rectosigrnoid 
yields 4-6 x 106 cells. 
Preparation of permeable smooth muscle cells : To test substances such as Ins(1,4,5)P3, PKC 
or the G protein antisera, which do not readily pass across the cell membrane, cells from the 
rectosigmoid are made permeable without affecting their overall function (18). The partly digested 
muscle tissue is washed with 50 ml of a "cytosolic" enzyme-free medium (cytosolic buffer) with the 
following composition (millimolar): NaCI(20), KCI(100), MgSO4(5.0), NaH2PO4(0.96), 
NaHCO3(25.0), EGTA (1.0), CaC12 (0.48). The medium contains 2% bovine serum albumin and 
is equilibrated with 5% 02/95% CO2 to maintain a pH of 7.2. Muscle cells are allowed to disperse 
spontaneously in this medium and are harvested by filtration on 500urn Nitex mesh. Isolated cells 
are permeabilized by incubation for 3 rain in saponin (75ktg/mi). The cell suspension is then washed 
in cytosolic buffer. The cell suspension is filtered through 10-1~m Nitex mesh; cells retained on the 
filter are washed free of saponin and resuspended in the cytosolic buffer containing antimycin 
(10 I~M), ATP (1.5 mM), and an ATP-regenerating system consisting of creatinine phosphate 
(5 raM) and creatinine phosphokinase (10 units/ml). 
Permeabilized cells from the rectosigmoid were incubated with the G protein antisera for one 
hour before the addition of the contractile agonists. 
Measurement of Contraction: Muscle cells are usually examined within 30 min of dispersion. 
Aliquots consisting of 2.5 x 104 cells in 0.5 ml of medium are added to 0.1 ml of  a solution 
containing the test agents. The agents are agonists, singly or in combination, or combinations of 
agonists and antagonists. In kinetic experiments the reaction is interrupted at various intervals (5 sec 
to 8 min) by the addition of 0.1 ml of acrolein at a final concentration of 1%. In experiments where 
concentration-response characteristics are examined, the reaction is interrupted at the time of peak 
contractile response. Individual cell length is measured by computerized image micrometry. The 
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average length of cells in the control state or after addition of test agents is obtained from 50 cells 
encountered randomly in successive microscopic fields. The contractile response is defined as the 
decrease in the average length of the 50 cells and is expressed as the absolute change or the percent 
change from control length (17). 
G-protein antisera: G-protein antisera were utilized to test the involvement of  specific Ga 
subunits in the signal transduction pathway of endothelin induced contraction. Antisera generated 
against short peptide sequences of Ga subunlts were obtained from DuPont NEN (Boston, MA). 
The antibodies have been shown to have the following specificities: RM/I: binds to Gsa alone 
(19), EC]2: binds Gi3>Go>>>Gil = Gi2, AS/'/: binds Gil = Gi2 >> Gi3, not to Go (20) (also 
transducin), GC/2: binds Go only (21). After resuspension in cytosol-like buffer, the cells were 
preincubated with the antibodies at a final dilution of 1:100 for 60 rain. At the end of the 60 rain., 
the same procedure was used as described before except smaller volumes were used due to the 
scarcity of the antibody. Aliquots of 0.1 ml ceUs were used and all the other volumes were reduced 
accordingly. 
Materials: Collagenase (CLS type II) was obtained from Wortington. Endothlelin-1 was 
obtained from Peninsula Laboratories (Belmont, CA). All other materials were obtained from Sigma 
(St. Louis, MO). 
Results 
Endothelin induced contraction of smooth muscle cells from the rectosigmoid: The response to 
endothelin ET-1 was concentration-dependent (Fig. 1). A threshold response was attained at 
10-1°M, a half-maximal response was observed at 10 -8 M. The response observed at 10-6M was not 
significantly different from the maximal response to acetylcholine (35.7 + 1.2% versus 36.08 + 
2.42% decrease in cell length from control). The kinetics of contraction of rectosigrnoid cells in 
response to endothelin is shown in Fig. 2. Endothelin-induced contraction peaked at 60 seconds 
36.08 + 2.42% and was sustained for up to 8 minutes (Fig. 2A). In the absence of calcium from the 
extracellular medium (0Ca~/2mM EGTA), the kinetics of the contractile response to endothelin was 
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The response of smooth muscle cells from the reetosigmoid of the rabbit. Smooth 
muscle cells were incubated with the indicated concentration of endothelin ET- 1 for 
30 seconds. The data are shown as mean + gEM of 3 experiments. 
altered. The sustained contractile response observed in normal buffer was changed to a transient 
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response, where the initial peak response was followed by a time dependent decline (Fig. 2B). The 
response is similar to the contraction induced by other peptides like substance P or CCK (22, 23), 
that do exhibit transient responses indicating that the maintenance of the sustained contraction is 
totally dependent upon influx of calcium from extracellular sources. 
Eff.ect of preincubation with antisera to G-proteins: Permeabilization of rectosigmoid cells with 
saponln and resuspension in a cytosol-like medium had no effect on cell length in the resting state 
(intact cells, 62.3 + 2.2 ~tm; permeabilized cells, 61.3 + 3.0 ~tm (mean + S.E.)). Intact and 
permeabilized cells contracted identically in response to endothelin 10-6M (36.2 + 3.0 versus 35.6 + 
2.1% decrease in cell length from control) (Fig. 3). 
Preincubation of permeabilized ceils with the antisera RM/I(Gsc0 or GC/2 (Go) had no effect on 
the contractile response to endothelin (Fig. 3) indicating that the contractile response induced by 
endothelin was not affected by the preincubation technique. Preincubation with antiserum EC/2 
(Gi3ct) resulted in a significant inhibition of contraction at 30 sec, but no inhibition of contraction at 
2-4 minutes implying that Gi3 subunit mediates the initial transient response induced by endothelin. 
Preincubation with the antiserum ASH (Gil_2ct) did not affect the transient contraction observed at 
30 sec, but significantly inhibited the sustained response at 2 and 4 min, implying that a Gil or 
Gi2tx subunit mediates the sustained contraction. 
As mentioned earlier, no inhibition of contraction was seen when antisera specific for Go (GC) 
or Gs (RM) were utilized, thus Go and Gs do not appear to be involved in endothelin induced 
contraction. 
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Figure 2 
Smooth muscle cells were incubated with endothelin (10-6M) for the indicated time. 
Endothelin induced contraction in normal Hepes buffer (Panel A) peaks and remains 
elevated for up to 8 minutes later. In the absence of Ca ++ in the medium (0Ca/2mM 
EGTA) (Panel B), endothelin induced contraction peaks at 30 seconds and decreased 
in a time dependent manner. Data are expressed as mean + SEM of 3 experiments. 
Discussion 
Endothelin has been shown to be present in the rat and human gastrointestinal tract (14,15). 
High endothelin binding sites were shown to be present in muscle layer of the rat ileum. Our data 
indicate the presence of high affinity receptors for endothelin on isolated circular smooth muscle 
ceils from the rabbit rectosigmoid. The higher efficacy observed in the rat colon vs the rabbit colon 
could be due to a species difference. 
The vasoconstrictor effects of ET-I are long-lasting. In gastrointestinal smooth muscle, in the 
presence of extracellular calcium, endothelin induced prolonged contraction while in the absence of 
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extracellular calcium contraction was transient. Thus the response consists of two phases, an initial 
rapid phase which is independent of extracellular calcium and a slower prolonged phase which 
requires extracellular calcium. These two phases appear to correlate with the involvement of 
different G-proteins. A Gi3-1ike protein appears to be required for the initial rapid transient phase of 
contraction and a Gil or Gi2-1ike protein is required for the prolonged phase. 
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Permeabilization of rectosigmoid cells with saponin and resuspension in a cytosol- 
like medium had no effect on cell length in the resting state. Intact and permeabilized 
cells contracted identically in response to endothelin (10-6M). Permeabilized cells 
from the rectosigrnoid were incubated with the antiserum for one hour before the 
addition of the contractile agonists. When saponified cells were incubated with the G 
protein antiserum to Gsct or Go(x, there was no effect on the contraction induced by 
endothelin. Preincubation with antiserum EC/2 (Gisa) resulted in a significant 
inhibition of contraction at 30 sec, but no inhibition of contraction at 2-4 minutes. 
Preincubation with the antiserum AS/7 (Gil.2ct) did not affect the transient 
contraction observed at 30 sec, but significantly inhibited the sustained response at 2 
and 4 min. Data are expressed as mean + SEM of 3 experiments. 
Endothelin was originally identified as a potent vasoconstrictor, but has later been shown to have 
a wide variety of biological activities on nonvascular tissues, including neurotransmission (24,25). 
Endothelin has been shown to be a neuropeptide in the human intestine with binding sites on neural 
plexuses (15), suggesting a role in the modulation of intestinal motility as a candidate autocrine 
neuromodulator. Two distinct receptors for endothelin have been described. Those receptors 
probably serve different functions. There is a possibility that ET-1 activates the two subtypes of 
receptors which then couple specifically to the two G-proteins. Although both receptors may couple 
to both G-proteins mediating the two phases of contraction. In either case the data demonstrates that 
each phase of the response is linked to a distinct G-protein. 
We propose a model whereby signal transduction by endothelin causes contraction of 
gastrointestinal smooth muscle by activating two different G-proteins which are coupled to distinct 
intracellular pathways: 1) Gi3 activating a phospholipase C resulting in Ptdlns(4,5)P2 hydrolysis 
and the formation of Ins-(1,4,5)P3 and 1,2-diacylglycerol. Ins-(1,4,5)P3 releases Ca m from stores 
inducing the formation of a Ca++-calmodulin complex, resulting in myosin light chain 
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phosphorylation and thus the initial phase of the contraction; and 2) a Gil-Gi2 activating PKC in 
the presence of 1,2-diacylglycerol and Ca m, resulting in the phosphorylation of other regulatory 
proteins (26) and thus inducing a calmodulin-independent (18) sustained contraction. 
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